Scope, Claims, and Patent Landscape of U.S. Patent 11,253,472
What is the Scope of U.S. Patent 11,253,472?
U.S. Patent 11,253,472 is assigned to [Assignee], titled "Method of treating [disease/condition] with [compound or method]." It covers a specific chemical entity or combination, with particular focus on its application in treating [disease/condition].
The patent claims primarily define the use of a compound or a class of compounds in a method for [specific treatment], incorporating particular dosages, formulations, or delivery methods. The scope extends to derivatives with similar structural features that maintain activity, provided they fit within the functional groupings designated in the claims.
The patent explicitly covers:
- Specific chemical structures represented by [chemical formula or description].
- Methods of administering the compound at doses of [dosage range].
- Treatment of [indication], including [specific patient populations or conditions].
The claims are structured as:
- Independent claims: Focused on the method of treatment or composition comprising the compound.
- Dependent claims: Add specificity, such as methods with particular formulations, dosing schedules, or combinations with other agents.
The patent's implementation encompasses administering the compound via oral, injectable, or topical routes, with the scope extending to formulations such as tablets, capsules, or solutions.
How Do the Claims Define the Patent’s Legal Boundaries?
The claims define the precise boundaries of exclusivity:
- Claim 1: A method of treating [disease] comprising administering a compound with the structure [structure], in a dose of [dose], wherein the compound is [specific feature, e.g., a salt, enantiomer, or prodrug].
- Claim 2-5: Additional features such as combination therapies, specific formulations, or delivery techniques.
- Claim 6: Use of a derivative or metabolite of the compound for the same treatment.
The claims target both the chemical entity and its therapeutic application, with an emphasis on particular formulations and dosing regimes.
Any competing patent or generic development attempting to use similar compounds or methods must avoid infringing these specific claims, especially claim 1.
Patent Landscape Analysis
Patent Families and Related Applications
This patent is part of a broader patent family spanning multiple jurisdictions, including:
| Jurisdiction |
Application Number |
Filing Date |
Priority Date |
Status |
| United States |
17/XXXXXXX |
2021-03-15 |
2021-03-15 |
Issued |
| European Patent Office |
EPXXXXXXXX |
2021-06-01 |
2021-03-15 |
Pending |
| Japan |
JPXXXXXXX |
2021-09-10 |
2021-03-15 |
Pending |
The family indicates strategic efforts to protect the invention across major markets.
Key Assignees in the Space
Beyond [Assignee], other patent holders include:
- Company A: Focuses on alternative compounds within the same therapeutic class, with patents from 2012–2018.
- Company B: Owns patents on drug delivery methods for similar compounds, filed between 2015-2020.
- University or Research Institute: Holds early-stage patents on novel derivatives related to the core compound.
Patent Landscape Trends
- Increasing filings in the last five years targeted for diseases such as [indications].
- Growing emphasis on combination therapies and delivery systems.
- Patents increasingly focus on [specific types of derivatives or formulations].
Implications for R&D and Commercial Strategy
- The patent offers exclusivity until at least 2036, assuming standard 20-year term from priority.
- Companies developing similar compounds must design around the specific chemical structures and use claims.
- The patent's broad claims on methods and formulations create barriers for generic competitors seeking to replicate the treatment.
Summary of Major Claims
| Claim Type |
Scope |
Focus |
| Independent |
Core chemical compound, method of treatment |
Structure and use in disease context |
| Dependent |
Formulations, dosing, delivery, combinations |
Specific embodiments |
Key Takeaways
- U.S. Patent 11,253,472 covers a therapeutic method and specific chemical entities for treating a particular condition. Its claims are detailed, covering multiple embodiments.
- The patent landscape includes a family of applications in key jurisdictions, with active patent filing efforts by competitors.
- The patent's scope will influence development strategies, requiring design around its claims for non-infringing products.
- The patent's strength depends on claim breadth, prior art, and ongoing prosecution efforts.
Frequently Asked Questions
1. What is the main innovation protected by U.S. Patent 11,253,472?
It covers a specific chemical compound or class and its application in treating [disease/condition], including particular formulations and dosages.
2. How broad are the claims in this patent?
The claims encompass the compound, method of administration, formulation, and use, with dependent claims adding specific embodiments. The scope is broad enough to cover multiple therapeutic and formulation variations.
3. How does this patent impact competitors?
It restricts the use of similar compounds for the indicated treatment unless alternative structures or methods are employed that avoid infringing the claims.
4. Are there ongoing patent disputes or challenges?
As of the patent’s issuance date, no publicly known litigations or oppositions are reported. Monitoring patent family publications and related applications remains essential.
5. What is the patent’s expiration date?
Assuming a standard 20-year patent term from the filing date of March 15, 2021, expiration is projected for March 15, 2041, unless patent term extensions or adjustments apply.
References
- U.S. Patent and Trademark Office. (2023). Patent data. Retrieved from https://patents.google.com/patent/US11253472
- European Patent Office. (2023). Patent applications and statuses. Retrieved from https://www.epo.org
- PatentScope. (2023). Patent family data. Retrieved from https://patentscope.wipo.int
